Inactive Instrument

News Yew Bio-Pharm Group Inc OTC Bulletin Board

Equities

US98584C1018

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	22-03-29	AQ
Yew Bio-Pharm Group, Inc. Announces Yongchun Shi and Mr. Xiefeng Liu Resigned as the Independent Director	22-03-29	CI
YEW BIO-PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-11-15	AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-08-16	AQ
Yew Bio-Pharm Group, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	21-07-27	AQ
Yew Bio-Pharm Group, Inc. Announces Executive Changes	21-07-27	CI
Yew Bio-Pharm Group, Inc. Announces Executive Changes	21-07-27	CI
Yew Bio-Pharm Group, Inc. Announces Executive Changes	21-07-27	CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-05-17	AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
YEW BIO P : PHARM GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-03-30	AQ
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Yew Bio Pharm : Announces New Cosmetic Subsidiary	21-03-09	AQ
Yew Bio-Pharm Group, Inc. Announces New Cosmetic Subsidiary	21-03-09	CI
YEW BIO-PHARM GROUP, INC. : Change in Directors or Principal Officers (form 8-K)	21-01-05	AQ
Yew Bio-Pharm Group, Inc. Announces Resignation of Guoshuang Tian as Director	21-01-05	CI
Yew Bio-Pharm Group, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
YEW BIO PHARM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-11-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Yew Bio-Pharm Group Inc OTC Bulletin Board

Equities

US98584C1018

Summary

Filters